Advertisement
Advertisement
U.S. markets close in 12 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Taro Pharmaceutical Industries Ltd. (TARO)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
34.56+0.55 (+1.62%)
As of 03:30PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close34.01
Open34.23
Bid34.53 x 1000
Ask35.09 x 1100
Day's Range33.99 - 34.86
52 Week Range33.36 - 72.97
Volume4,801
Avg. Volume32,129
Market Cap1.299B
Beta (5Y Monthly)0.74
PE Ratio (TTM)13.99
EPS (TTM)2.47
Earnings DateOct 26, 2022 - Oct 31, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 10, 2018
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-11% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for TARO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Taro Pharmaceutical Industries
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    22 days agoMorningstar
View more
Advertisement
Advertisement